Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Vilazodone

Copy Product Info
🥰Excellent
Catalog No. T1279Cas No. 163521-12-8
Alias SB659746A, EMD 68843

Vilazodone (SB659746A) is a selective serotonin (5-HT) reuptake inhibitor (SSRI) and a 5-HT-1A receptor partial agonist, with antidepressant and anti-anxiety activities. Vilazodone inhibits the reuptake of serotonin from the synaptic cleft while stimulating the release of 5-HT into the synaptic cleft. This increases the concentration of 5-HT in the synaptic cleft and potentiates serotonergic neurotransmission in the central nervous system.

Vilazodone

Vilazodone

Copy Product Info
🥰Excellent
Purity: 99.61%
Catalog No. T1279Alias SB659746A, EMD 68843Cas No. 163521-12-8
Vilazodone (SB659746A) is a selective serotonin (5-HT) reuptake inhibitor (SSRI) and a 5-HT-1A receptor partial agonist, with antidepressant and anti-anxiety activities. Vilazodone inhibits the reuptake of serotonin from the synaptic cleft while stimulating the release of 5-HT into the synaptic cleft. This increases the concentration of 5-HT in the synaptic cleft and potentiates serotonergic neurotransmission in the central nervous system.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$54In StockIn Stock
5 mg$127In StockIn Stock
10 mg$197In StockIn Stock
25 mg$278In StockIn Stock
50 mg$329In StockIn Stock
1 mL x 10 mM (in DMSO)$154In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.61%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Vilazodone AI Summary
Vilazodone exhibits potent bioactivities related to serotonin regulation and has demonstrated interactions with various neurotransmitter systems. It has a high affinity for the human 5-HT1A receptor (Ki = 0.2 nM) and exhibits agonist activity at this receptor with an EC50 value of 0.12 nM. The compound effectively inhibits the serotonin transporter (SERT) with an IC50 value ranging from 0.4 to 0.5 nM, indicating its potential to modulate serotonin levels. Additionally, it shows inhibitory activity against the dopamine receptors (D2, D3, D4), adrenergic receptors (alpha-1, alpha-2), histamine H1 receptor, and rat cortex acetylcholinesterase (AChE) with an IC50 of 21300.0 nM. In antiviral assays, Vilazodone displays activity against SARS-CoV-2 with modest inhibition rates, including a hit score of 0.1122 in HRCE cells and a 0.71% inhibition rate of SARS-CoV-2 induced cytotoxicity in VERO-6 cells. It also inhibits the SARS-CoV-2 3CL-Pro protease by approximately 9.82% at 20 µM. Metabolic stability of Vilazodone is moderate to low in liver microsomes, with half-lives around 0.4-0.474 hours in rat, mouse, and human models. These findings, combined with good permeability in PAMPA-BBB assays and moderate inhibition of several cytochrome P450 enzymes, suggest potential challenges in drug-drug interactions and systemic exposure. The compound also demonstrates antidepressant properties in mice, reducing immobility time by 60% at a dose of 40 mg/kg for 7 days. It exhibits cytotoxicity in human HepG2 cells with an IC50 value of 6100.0 nM. Overall, Vilazodone is a promising serotonin modulator with potential therapeutic implications in serotonin-related disorders, although further research is needed to address its metabolic stability and broad receptor interactions..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Vilazodone (SB659746A) is a selective serotonin (5-HT) reuptake inhibitor (SSRI) and a 5-HT-1A receptor partial agonist, with antidepressant and anti-anxiety activities. Vilazodone inhibits the reuptake of serotonin from the synaptic cleft while stimulating the release of 5-HT into the synaptic cleft. This increases the concentration of 5-HT in the synaptic cleft and potentiates serotonergic neurotransmission in the central nervous system.
SynonymsSB659746A, EMD 68843
Chemical Properties
Molecular Weight441.52
FormulaC26H27N5O2
Cas No.163521-12-8
SmilesNC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1
Relative Density.1.34 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 68.57 mg/mL (155.3 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.53 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2649 mL11.3245 mL22.6490 mL113.2452 mL
5 mM0.4530 mL2.2649 mL4.5298 mL22.6490 mL
10 mM0.2265 mL1.1325 mL2.2649 mL11.3245 mL
20 mM0.1132 mL0.5662 mL1.1325 mL5.6623 mL
50 mM0.0453 mL0.2265 mL0.4530 mL2.2649 mL
100 mM0.0226 mL0.1132 mL0.2265 mL1.1325 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Vilazodone | purchase Vilazodone | Vilazodone cost | order Vilazodone | Vilazodone chemical structure | Vilazodone formula | Vilazodone molecular weight